something i see skipped constantly: verifying that what shipped is actually what you ordered. ordered additive-free and got a vial that looks different than expected? most people shrug and inject anyway. that’s how you end up with benzyl alcohol in a tissue protocol where it actively works against you. practical steps i run on anything from a new pharmacy: cold chain first. arrived warm? that’s your first data point. track the shipping time and whether it came with an ice pack. document it, don’t assume it’s fine. COA verification. ask for the COA tied to your actual lot number, not a generic PDF off their website. legit compounders can provide this. if they send you a generic with no lot reference, that’s information. excipients. most COAs list them. benzyl alcohol, BA/BB, sodium chloride, it should all be there. “additive-free” means no BA, usually just BAC water or sterile water. confirm before you reconstitute, not after. visual check post-recon. cloudy? particulates? off-color? BPC reconstitutes clear and stays clear. TB-500 same. anything suspicious, set it aside and contact the pharmacy before dosing. none of this is complicated but i see people skip straight to injection after waiting three weeks for an order. the impatience makes sense. the shortcut doesn’t. learned the hard way in 2021 that COA on file is not the same as COA for your lot. imo cost me a full protocol
The case for lot-specific COA is solid. No argument with the cold chain or excipient checks either. But there’s a gap this list doesn’t fully close: the COA is a point-in-time document from when the batch left the compounder’s lab. Cold chain failure between there and your door doesn’t appear on it. And “reconstitutes clear” catches gross contamination, not degradation. BPC that spent 48 unrefrigerated hours in transit can still reconstitute clear and look exactly right. What’s missing from this checklist is batch-level logging across cycles. Same supplier, same compound, same declared purity on the COA, completely different behavior depending on the lot. Found that out the hard way: two cycles, same vendor, different lots, enough protocol consistency to see the discrepancy against my pain scores. COA was clean on both. Outcomes weren’t comparable. The compounding situation over the last year is what pushed me from supplier-level tracking to batch-level logging specifically. Lot-specific COA is necessary, not sufficient. You need longitudinal batch data to tell whether a given lot actually performs consistent with your baseline. Without it, you’re doing point-in-time verification and calling it due diligence. ymmv depending on how deep your cycle log goes, but one vial’s worth of documentation doesn’t tell you much.
eta: one more thing
One thing missing from the checklist is the BAC water itself as its own variable. Most people treat the diluent as inert and source it from whichever cheap supplier ships fastest, but benzyl alcohol concentration isn’t standardized across vendors and the cheaper stuff irritates subq tissue noticeably more on repeat injections in the same area. I ran my BPC solo cycle injecting close to the surgical site twice daily for four weeks, and the water source mattered enough that I switched mid-cycle when site reactions started showing up. Worth asking your compounder what they recommend, or at least keeping the water source consistent across a cycle so you’re not stacking variables when troubleshooting irritation. The other piece nobody talks about is freeze/thaw on the reconstituted vial. Even a clear, COA-verified peptide degrades faster than people assume if the fridge cycles warm during a power blip, and that’s a confound you won’t catch visually. Boring stuff but it’s the kind of thing that quietly undoes a protocol.
visual check post-recon is the right gate but it’s a low-resolution one. clear and stays clear catches gross contamination and obvious reconstitution failure, but it won’t catch a mislabeled excipient at concentrations that still pass visually. benzyl alcohol in a “additive-free” vial isn’t going to cloud anything. you’d need the COA to catch it, which is exactly why your COA-for-the-lot point is the load-bearing step in the checklist, not the visual one. the other piece i’d add is that the cold chain data point isn’t binary. arrived warm vs arrived cold is the easy read, but BPC and TB-500 both have different stability profiles lyophilized vs reconstituted, and “warm for 18 hours in transit while still lyo” is a different question than “warm for 18 hours post-recon.” most pharmacies ship lyophilized which buys you a lot of margin, but i’ve seen people panic about a warm-arrival lyo shipment and toss it when the degradation math doesn’t really support that. ymmv and i’d rather overcaution than under, but it’s worth knowing which state your peptide was in when the cold chain broke. 2021 lesson tracks. the gap between “COA on file” and “COA for your lot” is exactly the kind of thing nobody flags until it costs them a cycle.
The 2021 lesson is the one that should be in bold, not the steps. COA on file vs COA for your lot is exactly the gap that catches careful people, because the careful people are the ones who already asked for a COA and then stopped asking. Once you’ve got a PDF in hand the checklist feels done. It isn’t. One thing i’d add to “arrived warm? that’s your first data point.” A vial that arrived cold and clear isn’t proof of an intact cold chain, it’s proof of the last leg of it. The compounder’s lab tested at fill. Whatever happened between their freezer and the carrier’s truck doesn’t show up on the COA and doesn’t necessarily show up visually post-recon either. “Reconstitutes clear” catches gross contamination. Catches degradation poorly. BPC especially, the visual signal isn’t sensitive enough to flag a vial that sat on a loading dock in July. The other piece worth naming: a supplier switch mid-cycle is a protocol seam, not a footnote. Two batches across one run is two protocols back-to-back, and the seam usually lands right inside whatever measurement window you set up. I’ve eaten that one. If you’re running a 4-week BPC cycle and reorder at week 2, you didn’t run one protocol, you ran two, and any signal change at week 3 is unreadable. so the practical extension of your list: log lot numbers per dose, not per order. when the second vial cracks open mid-cycle, that’s a marker on the chart, not an asterisk. ymmv but it’s saved me twice.
Batch-level logging is the part I’d push back on slightly, not because it’s wrong but because most people aren’t running enough cycles with enough protocol consistency to generate signal worth analyzing. You need a lot of controlled variables to attribute outcome differences to the lot rather than PT, sleep, concurrent loading, stress. That said, your core point stands: “reconstitutes clear” does not rule out degradation, and I’ve seen exactly that scenario with warm transit. COA clean, visual clean, results noticeably flat compared to prior cycles. That’s real.
fair point on the n-problem. you’re right that most people running two cycles a year can’t actually attribute a flat outcome to lot vs sleep vs the three other things they changed. the statistical case for batch logging as a controlled-variable analysis isn’t there for most users, including me honestly. but i think batch logging serves a different function than the one you’re pushing back on. it’s not really there to do attribution math after the fact. it’s there as a search-space narrower when something does go sideways. if i run a cycle and week 3 feels noticeably different from prior runs at the same dose and site rotation, having “lot #X received Y date, arrived at Z temp, reconstituted on this date” logged means i can call the pharmacy with specifics instead of “i think it was the batch from march.” they can pull their records, i can pull mine, and we can sometimes actually triangulate something useful. without the log it’s just vibes. the other thing batch logging catches that protocol-level logging doesn’t: silent supplier substitutions. compounder switches their API source, or their BAC water vendor, or repackages from a different sub-lot, and nothing about your protocol changed but your inputs did. you don’t know that happened unless you logged lot numbers across time. the compounding situation this past year is what pushed me from per-supplier to per-batch. before that i’d have called it overkill too. so i’d reframe it: batch logging isn’t trying to generate attribution-grade signal from n=2 cycles. it’s cheap insurance that pays off in the specific scenarios where you need it. takes maybe 30 seconds per delivery to write down lot, receive date, arrival temp. the cost is trivial, the alternative when something goes wrong is “i have no idea which vial it was.” ymmv on whether the rare payoff is worth the habit, but the bar is low enough that i think it clears for most people running multi-cycle protocols.
edit: typo